Abstract:The purpose of this study was to investigate the expression of microRNA-106b (miR-106b) and phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in pituitary tumor and to confirm whether miR-106b promotes proliferation and invasion of pituitary tumor cells through the PI3K/AKT signaling pathway by targeted regulation of PTEN expression, and thereby to find new targets for the treatment of pituitary tumor. Fifty-five cases of pituitary tumor tissue samples were collected, including 29 cases of invasive pituitary tumor, non-invasive 26 cases, and 8 normal pituitaries. The expression level of miR-106b in pituitary tumor tissue was detected by quantitative real-time PCR, and the expression of PTEN protein was detected by immunohistochemistry. PTEN 3′-untranslated region (UTR) luciferase vector was constructed, and dual-luciferase reporter gene assay was employed to examine the effect of miR-106b on PTEN 3′-UTR luciferase activity. AtT-20 cells were transfected with miR-106b mimics, miR-106b inhibitor, PTEN expression plasmid, and miR-106b mimics + PTEN expression plasmid respectively, and the changes in cellular proliferation and invasion were observed via MTT method and transwell assay respectively. PTEN messenger RNA (mRNA) expression was determined by quantitative real-time PCR, and western blotting was performed to detect the expression of PTEN, PI3K, AKT, and pAKT. miR-106b showed up-regulation in invasive pituitary tumor tissue: the expression level was significantly up-regulated compared with normal tissues and the non-invasive pituitary tumor tissue (P < 0.05). The positive rate of PTEN protein expression in invasive pituitary tumor tissues was significantly lower than in normal and non-invasive tissues (P < 0.01). Dual-luciferase reporter gene assay showed that miR-106b could bind to the 3ʹ-UTR of PTEN specifically and significantly inhibited the luciferase activity, cutting the 46 % (P < 0.01). Down-regulation of miR-106b or up-regulation of PTEN could suppress cell proliferation and invasion of AtT-20 cells, and PTEN expression plasmid could partially simulate the function of miR-106b. Expression of PTEN mRNA and protein decreased significantly in AtT-20 cells overexpressing miR-106b. The expression levels of PI3K and p-AKT were significantly inhibited by miR-106b inhibitor and increased by miR-106b mimics. The expression of miR-106b showed up-regulation in pituitary tumor tissues, while the protein expression of PTEN presented opposite results. The findings of this study further demonstrated that miR-106b as an oncogene regulated the pituitary tumor cell proliferation and invasion in vitro by directly targeting PTEN through the PI3K/AKT signaling pathway. Our study suggests that miR-106b and PTEN are likely to serve as potential diagnostic biomarkers or therapeutic targets for pituitary tumor treatment in the future.

The Experimental Study of Mirna in Pituitary Adenomas.

Expression Profile And Clinical Significance Of Micrornas In Papillary Thyroid Carcinoma

IsolationThe role of microRNA in the diagnosis and treatment of pituitary adenomas

The Gene Expression Profiles of Pituitary Adenomas Studied by Cdna Microarray

Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas Were Identified by Using Analysis of Micrornas Expression Profile

[Differential expression analysis of prolactinoma-related microRNAs]

Microrna Expression Profiling Of The Porcine Developing Hypothalamus And Pituitary Tissue

MicroRNA-30d Target TIMP3 Induces Pituitary Tumor Cell Growth and Invasion.

133 Distinctive Mirna Expression Profiles in Tissue and Serum of Primary Extramammary Pagets Disease

Characteristics of Micrornas Enriched in Specific Cell Types and Primary Tissue Types in Solid Organs.

Gene expression profiling in human null cell pituitary adenoma tissue

MicroRNAs and Target Genes in Pituitary Adenomas

Preliminary study on miRNA in prostate cancer

MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN

Differential Expression Profile of Micrornas in Clear Cell Renal Cell Carcinoma

Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma

The Use of Hsa-Mir-21, Hsa-Mir-181b and Hsa-Mir-106a As Prognostic Indicators of Astrocytoma.

The emerging role of miRNAs in pituitary adenomas: From molecular signatures to diagnostic potential

MicroRNA expression profiling in the colorectal normal-adenoma-carcinoma transition

Microrna Expression Profiling of Nasopharyngeal Carcinoma.

Pit-1 Mrna And Protein Expression In Human Pituitary Adenomas